Scott I. Klein

607 total citations
19 papers, 507 citations indexed

About

Scott I. Klein is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Scott I. Klein has authored 19 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Genetics. Recurrent topics in Scott I. Klein's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Scott I. Klein is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Scott I. Klein collaborates with scholars based in United States and Switzerland. Scott I. Klein's co-authors include I. Danishefsky, Alfred P. Spada, Valeria Chu, Henry W. Pauls, J.P. Guilloteau, Robert J. Leadley, S. Maignan, Uttam Pati, Michael R. Becker and Yong Mi Choi-Sledeski and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Scott I. Klein

19 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott I. Klein United States 14 221 161 122 67 56 19 507
Carl Crysler United States 19 304 1.4× 325 2.0× 71 0.6× 53 0.8× 31 0.6× 37 782
Daniel J. Burdick United States 13 353 1.6× 96 0.6× 63 0.5× 57 0.9× 30 0.5× 19 613
Mary Pat Beavers United States 17 408 1.8× 192 1.2× 53 0.4× 52 0.8× 19 0.3× 25 729
Chu‐Biao Xue United States 22 577 2.6× 320 2.0× 76 0.6× 49 0.7× 28 0.5× 52 1.0k
Moshe Weitzberg United States 15 242 1.1× 266 1.7× 58 0.5× 47 0.7× 8 0.1× 28 638
Kevin R. Kupcho United States 10 481 2.2× 80 0.5× 81 0.7× 40 0.6× 17 0.3× 22 707
Yasuhiro Imaeda Japan 17 828 3.7× 161 1.0× 234 1.9× 60 0.9× 65 1.2× 30 1.1k
Adel M. Naylor-Olsen United States 14 286 1.3× 269 1.7× 193 1.6× 47 0.7× 60 1.1× 23 598
Geeta Patel United Kingdom 18 288 1.3× 224 1.4× 102 0.8× 5 0.1× 39 0.7× 45 732
Austin Vogt United States 11 517 2.3× 34 0.2× 164 1.3× 97 1.4× 15 0.3× 19 768

Countries citing papers authored by Scott I. Klein

Since Specialization
Citations

This map shows the geographic impact of Scott I. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott I. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott I. Klein more than expected).

Fields of papers citing papers by Scott I. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott I. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott I. Klein. The network helps show where Scott I. Klein may publish in the future.

Co-authorship network of co-authors of Scott I. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Scott I. Klein. A scholar is included among the top collaborators of Scott I. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott I. Klein. Scott I. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Subasinghe, Nalin L., Carl R. Illig, Matthias Rudolph, et al.. (2004). A novel series of potent and selective small molecule inhibitors of the complement component C1s. Bioorganic & Medicinal Chemistry Letters. 14(12). 3043–3047. 18 indexed citations
2.
Klein, Scott I., Kevin R. Guertin, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency. Bioorganic & Medicinal Chemistry Letters. 12(12). 1667–1670. 14 indexed citations
3.
Guertin, Kevin R., Scott I. Klein, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 12(12). 1671–1674. 45 indexed citations
4.
Rebello, Sam, Charles Kasiewski, Ross Bentley, et al.. (2001). Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs. Thrombosis Research. 102(3). 261–271. 13 indexed citations
5.
Heran, Christopher L., Charles Kasiewski, Jeffrey S. Bostwick, et al.. (2000). Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis. European Journal of Pharmacology. 389(2-3). 201–207. 23 indexed citations
6.
Maignan, S., J.P. Guilloteau, Stéphanie Pouzieux, et al.. (2000). Crystal Structures of Human Factor Xa Complexed with Potent Inhibitors. Journal of Medicinal Chemistry. 43(17). 3226–3232. 116 indexed citations
7.
Klein, Scott I., Bruce F. Molino, Valeria Chu, et al.. (1998). Design of a New Class of Orally Active Fibrinogen Receptor Antagonists. Journal of Medicinal Chemistry. 41(14). 2492–2502. 15 indexed citations
8.
Klein, Scott I., Kevin R. Guertin, Daniel L. Cheney, et al.. (1998). Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa. Journal of Medicinal Chemistry. 41(4). 437–450. 35 indexed citations
9.
Klein, Scott I., et al.. (1997). Constrained β-alanine based GpIIb/IIIa antagonists. Bioorganic & Medicinal Chemistry Letters. 7(13). 1773–1778. 18 indexed citations
10.
Klein, Scott I., Bruce F. Molino, Robert J. Leadley, et al.. (1996). Non-peptide fibrinogen receptor antagonists based upon a 4-substituted piperidine scaffold. Bioorganic & Medicinal Chemistry Letters. 6(12). 1403–1408. 3 indexed citations
11.
Bostwick, Jeffrey S., Charles Kasiewski, Valeria Chu, et al.. (1996). Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonist. Thrombosis Research. 82(6). 495–507. 8 indexed citations
12.
Klein, Scott I., Jeffrey M. Dener, Bruce F. Molino, et al.. (1996). O-benzyl hydroxyproline as a bioisostere for Phe-Pro: Novel dipeptide thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(18). 2225–2230. 10 indexed citations
13.
Youssefyeh, Raymond D., et al.. (1992). Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides. Journal of Medicinal Chemistry. 35(5). 903–911. 20 indexed citations
14.
Youssefyeh, Raymond D., et al.. (1992). Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides. Journal of Medicinal Chemistry. 35(5). 895–903. 20 indexed citations
15.
Klein, Scott I., et al.. (1992). 5051405 Anti-thrombotic peptides and pseudopeptides. Transfusion Science. 13(4). ii–ii. 1 indexed citations
16.
Ziegler, Frederick E., et al.. (1986). Practical routes to two functionalized decalones for the synthesis of quassinoids. The Journal of Organic Chemistry. 51(24). 4573–4579. 20 indexed citations
17.
Ziegler, Frederick E., et al.. (1985). Acyclic diastereoselection as a synthetic route to quassinoids: a Claisen rearrangement based strategy for bruceantin. Journal of the American Chemical Society. 107(9). 2730–2737. 35 indexed citations
18.
Danishefsky, I., et al.. (1977). Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III. Biochimica et Biophysica Acta (BBA) - General Subjects. 498(1). 215–222. 39 indexed citations
19.
Danishefsky, I., et al.. (1976). Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor. Thrombosis Research. 8(2). 131–140. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl Crysler Breakdown of academic impact, for papers by Daniel J. Burdick Breakdown of academic impact, for papers by Mary Pat Beavers Breakdown of academic impact, for papers by Chu‐Biao Xue Breakdown of academic impact, for papers by Moshe Weitzberg Breakdown of academic impact, for papers by Kevin R. Kupcho Breakdown of academic impact, for papers by Yasuhiro Imaeda Breakdown of academic impact, for papers by Adel M. Naylor-Olsen Breakdown of academic impact, for papers by Geeta Patel Breakdown of academic impact, for papers by Austin Vogt
Rankless by CCL
2026